Status:
COMPLETED
Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Blood Pressure
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study team will conduct a cluster randomized control trial in 10 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherenc...
Eligibility Criteria
Inclusion
- Individuals:
- Age\>18 years
- Presence of Hypertension as defined by either:
- Blood pressure ≥140/90
- Hypertension diagnosis
- Prescription for at least one antihypertensive medication
- Outpatient clinic visit in the NYULH between 06/1/2022 and 12/31/2025
- MAs, PCPs, LPNs, and RNs:
- A clinician from an NYULH ambulatory practice location.
- a. Eligible clinicians include physicians, medical assistants, licensed practical nurses, and registered nurses.
- Adult patients during appointments with eligible clinicians
- Age \> 18 years
Exclusion
- Patients who decline to be observed.
- The study team has no specific exclusion criteria for patients in chart review.
Key Trial Info
Start Date :
October 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 11 2025
Estimated Enrollment :
1726 Patients enrolled
Trial Details
Trial ID
NCT05349422
Start Date
October 6 2022
End Date
May 11 2025
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016